Niaspan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Condition:   Tobacco Use Disorder Interventions:   Drug: Psilocybin;   Drug: Niacin Sponsors:   Johns Hopkins University;   University of Alabama at Birmingham;   New York University;   National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials

Glycogen and Appetite
Condition:   Energy Intake Interventions:   Dietary Supplement: Exercise plus carbohydrate;   Dietary Supplement: Exercise plus niacin;   Other: Placebo Sponsor:   University of Bath Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2022 Category: Research Source Type: clinical trials